- The trend backdrop is active with a 23-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
PHM7
GER
Week ended 07 Aug 2026
Weekly Investor Report
Altria Group, Inc. · Consumer Defensive · Tobacco
Latest close
59.20 EUR
-1.9%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 2.1% above the Trend Line and sits at 62.9% of its 52-week range. The latest completed week returned -1.9%, after a -5.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 51/100.
Setup score
56
out of 100
Latest Close
59.20 EUR
7 Aug 2026
1W Return
-1.9%
latest completed week
4W Return
-5.2%
short-term follow-through
12W Return
-3.4%
quarterly tape
Trend Breadth
67.3%
35 of 52 weeks active
Volume Ratio
1.4x
vs 13-week average
- 2 reversal markers appear in the recent smart-money tape.
- Latest weekly return ranks in the weaker part of its sector group.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.9%
Latest completed week; four-week move -5.2%.
Indicator stack
82/59
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
51/100
25 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 2.1% above the Trend Line and sits at 62.9% of its 52-week range. The latest completed week returned -1.9%, after a -5.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8112-week average 0.90
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.81Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -5.2% over four weeks, -3.4% over 12 weeks, and 16.6% over one year. The current trend has remained active for 23 consecutive weeks.
Performance by holding period
Active trend streak23 weeks
Active weeks in one year35
Trend breadth67.3%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.59Latest activity-pressure read.
Pressure change-20.8%Four-week change in activity pressure.
Leadership0.32Latest relative-leadership reading.
RS change-97.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 85%
Model confidence 79%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength85/100Blend of value, momentum, and quality. Underlying universe rank 16; rank 1 is best.
Value70/100Relative valuation strength. Underlying universe rank 31; rank 1 is best.
Quality66/100Profitability and accounting quality. Underlying universe rank 35; rank 1 is best.
Momentum67/100Medium-term price momentum. Underlying universe rank 34; rank 1 is best.
Growth9/100Revenue and earnings growth. Underlying universe rank 92; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 12.3x Price divided by trailing earnings.
- Price / sales
- 4.9x Market value relative to trailing revenue.
- EV / EBITDA
- 10.0x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 7.2% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 72.6% Gross profit retained from each unit of revenue.
- Operating margin
- 60.5% Operating profit retained from revenue.
- Free-cash-flow margin
- 42.3% Free cash flow generated from revenue.
- Return on invested capital
- 51.8% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -1.5% Latest one-year revenue growth.
- EPS growth
- -37.7% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 5.4% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 6.2% Cash dividends relative to market value.
- Buyback yield
- 1.0% Net share repurchases relative to market value.
- Shareholder yield
- 7.2% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.8x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 25 relevant articles.
3 positive · 21 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-12.4%Distance below the 52-week high.
13-week volatility3.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+8.7%Week of 1 May.
Worst week-6.0%Week of 31 Jul.
Latest week-1.9%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains6
Flat weeks0
Modest losses9
Sharp losses5
Recent vol3.9%13-week weekly-return volatility.
Base vol3.8%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew3.5% / -2.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDE Consumer Defensive
4-week rank34 / 38
Group average3.9%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD73.7%positive activity pressure
RS31.6%positive relative leadership
Four-week leaders
IndustryDE Tobacco
4-week rank3 / 3
Group average-1.7%
Trend breadth66.7%
Trend66.7%active weekly trend signals
MD100.0%positive activity pressure
RS33.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape61/100
Trend, activity pressure, participation, and risk combine to a 61/100 tape read.
Indicator analysis84/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.81; 2 reversal markers Factors72/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 28 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment51/100Weighted news tone is neutral across 25 relevant articles.
Beverages, Alcohol, and Tobacco Stocks Q2 In Review: Altria (NYSE:MO) Vs Peers Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 59.20 EUR | -1.9% | 57.96 EUR | 44.20 EUR | 0.59 | 0.32 | 12.9K | On |
| 31 Jul 2026 | 60.34 EUR | -6.0% | 57.56 EUR | 44.02 EUR | 1.06 | 5.14 | 26.6K | On |
| 24 Jul 2026 | 64.16 EUR | -1.6% | 57.13 EUR | 43.84 EUR | 1.28 | 14.37 | 11.5K | On |
| 17 Jul 2026 | 65.20 EUR | 4.4% | 56.56 EUR | 43.63 EUR | 1.15 | 18.10 | 13.4K | On |
| 10 Jul 2026 | 62.48 EUR | -1.1% | 55.96 EUR | 43.42 EUR | 0.75 | 12.82 | 11.3K | On |
| 3 Jul 2026 | 63.20 EUR | -1.8% | 55.45 EUR | 43.22 EUR | 0.58 | 11.55 | 180 | On |
| 26 Jun 2026 | 64.34 EUR | 7.0% | 54.92 EUR | 43.02 EUR | 0.49 | 19.16 | 6.3K | On |
| 19 Jun 2026 | 60.14 EUR | -0.9% | 54.37 EUR | 42.81 EUR | 0.29 | 10.65 | 783 | On |
| 12 Jun 2026 | 60.68 EUR | -1.1% | 53.96 EUR | 42.63 EUR | 0.49 | 13.59 | 4.4K | On |
| 5 Jun 2026 | 61.33 EUR | 3.7% | 53.49 EUR | 42.44 EUR | 0.57 | 14.71 | 1.7K | On |
| 29 May 2026 | 59.17 EUR | -5.5% | 53.02 EUR | 42.25 EUR | 0.52 | 9.66 | 16.2K | On |
| 22 May 2026 | 62.59 EUR | 2.1% | 52.60 EUR | 42.08 EUR | 0.68 | 17.37 | 10.9K | On |
| 15 May 2026 | 61.31 EUR | 6.3% | 52.27 EUR | 41.88 EUR | 0.46 | 20.01 | 6.6K | On |
| 8 May 2026 | 57.65 EUR | -5.1% | 51.97 EUR | 41.69 EUR | 0.25 | 11.61 | 19.1K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.